Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
$12.63
+0.2850 ( +2.31% ) 705.2K
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
Market Data
Open
$12.63
Previous close
$12.34
Volume
705.2K
Market cap
$849.42M
Day range
$11.94 - $12.80
52 week range
$2.05 - $19.05
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Dec 12, 2023 |
8-k | 8K-related | 15 | Dec 08, 2023 |
8-k | 8K-related | 14 | Dec 06, 2023 |
8-k | 8K-related | 70 | Nov 28, 2023 |
8-k | 8K-related | 13 | Nov 17, 2023 |
10-q | Quarterly Reports | 83 | Nov 14, 2023 |
8-k | 8K-related | 15 | Nov 14, 2023 |
8-k | 8K-related | 14 | Oct 12, 2023 |
8-k | 8K-related | 59 | Sep 05, 2023 |
def | Proxies and info statements | 7 | Aug 22, 2023 |